| 摘要 |
<p>The present invention deals with a novel class of cyclic peptides with a selective IgG-binding activity and an inhibitory effect on the classical activation pathway of complement. These peptides may be pharmaceutically applied in compositions with an anti-inflammatory potential and further be used to enrich IgG from blood serum or plasma, to deplete plasma or serum from IgG, and/or to quantitate IgG levels in e.g. body fluids.</p> |
